| Literature DB >> 35203100 |
Ryan Rego1, Samuel Watson2, Paramjit Gill3, Richard Lilford2.
Abstract
OBJECTIVE: We systematically reviewed all studies published between 2000 and June 2021 that estimated under 5 diarrhoea rates in low- and middle-income countries and extracted data on diarrhoea rates, measurement methods and reactivity.Entities:
Keywords: WASH; child health; diarrhoea; epidemiology; surveillance
Mesh:
Year: 2022 PMID: 35203100 PMCID: PMC9313555 DOI: 10.1111/tmi.13739
Source DB: PubMed Journal: Trop Med Int Health ISSN: 1360-2276 Impact factor: 3.918
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| Reports diarrhoea rates among under 5s (i.e. incidence or prevalence) | Measures hospital‐acquired infection |
| Takes place in LMICs | Clinical trials in which diarrhoea was an adverse drug event |
| Published between 2000 and June 2021 | Case–control studies in which diarrhoea is the case |
| English or French language |
Data extracted for each observation
| Variable | Units (if applicable) | Categorisation (if categorised) |
|---|---|---|
| Authors | NA | NA |
| Study title | NA | NA |
| Year of publication | Years | NA |
| Year of data collection | Years | NA |
| Mean participant age | Years (with standard error) | NA |
| Participant sex breakdown | % Female | NA |
| Geography | Urban, rural or mixed | NA |
| Country | NA | Regions as defined by the United Nations Development Programme (UNDP) [ |
| Intervention (for randomised control trials [RCTs]) | NA | WASH, Health or Nutrition |
| Effectiveness of intervention (for RCTs) | Incidence risk ratio | NA |
| Diarrhoea rate (in incidence) | Episodes per child year (converted if necessary) | NA |
| Measurement type | NA | Passive, retrospective active, prospective (diary) active |
| Recall period | Days | NA |
| Questioning frequency | Days | Daily, weekly, monthly or annually or longer |
| Questioning type | NA | Pictorial, verbal or other |
| Sample size (observed cases for passive surveillance studies) | NA | NA |
| Study design | NA | Observational (primary), observational (secondary), RCT (broken down by arm) |
| Direct comparison of methods | NA | Yes/no |
Summary table of the 671 observations included in the systematic review, with average estimated diarrhoea rates for key variables
|
Passive
|
Prospective (diary) active
|
Retrospective active
| Total | Average estimated diarrhoea rate (episodes per child year) | ||
|---|---|---|---|---|---|---|
| Total | 25 | 13 | 633 | 671 | 6.75 | |
| Data collection year | 2016–2018 | 1 (2.9%) | 0 (0%) | 33 (97.1%) | 34 | 7.08 |
| 2011–2015 | 12 (6.8%) | 2 (1.1%) | 163 (92.1%) | 177 | 6.63 | |
| 2006–2010 | 6 (3.2%) | 2 (1.1%) | 180 (95.7%) | 188 | 6.60 | |
| 2001–2005 | 4 (3.4%) | 2 (1.7%) | 112 (94.9%) | 118 | 7.80 | |
| 1996–2000 | 2 (2.5%) | 1 (1.3%) | 77 (96.2%) | 80 | 6.15 | |
| 1991–1995 | 0 (0%) | 0 (0%) | 38 (100%) | 38 | 5.99 | |
| 1986–1990 | 0 (0%) | 3 (42.9%) | 4 (57.2%) | 7 | 3.54 | |
| Missing data | 0 (0%) | 3 (10.3%) | 26 (89.7%) | 29 | 7.46 | |
| Region | Sub‐Saharan Africa | 5 (1.9%) | 3 (1.1%) | 257 (97.0%) | 265 | 6.32 |
| North Africa and the Middle East | 0 (0%) | 0 (0%) | 23 (93.4%) | 23 | 6.56 | |
| Central and Southern Asia | 3 (1.7%) | 2 (1.1%) | 175 (97.2%) | 180 | 9.41 | |
| Eastern and South‐East Asia | 13 (21.0%) | 4 (6.4%) | 45 (72.6%) | 62 | 3.20 | |
| Oceania | 0 (0%) | 0 (0%) | 1 (100.0%) | 1 | 4.02 | |
| The Americas | 5 (3.6%) | 3 (2.1%) | 132 (94.3%) | 140 | 5.74 | |
| Study design | Observational (primary) | 19 (6.5%) | 11 (3.7%) | 264 (89.8%) | 294 | 8.21 |
| Observational (secondary) | 6 (3.2%) | 0 (0%) | 183 (96.8%) | 189 | 3.87 | |
| RCT (baseline or control) | 0 (0%) | 1 (1.1%) | 93 (98.9%) | 94 | 8.37 | |
| RCT (experimental post‐intervention) | 0 (0%) | 1 (1.1%) | 93 (98.9%) | 94 | 6.32 | |
| Geography | Mixed | 14 (5.8%) | 2 (0.8%) | 226 (93.4%) | 242 | 4.02 |
| Rural | 4 (1.8%) | 4 (1.8%) | 212 (96.3%) | 220 | 10.55 | |
| Urban | 4 (3.1%) | 7 (5.5%) | 116 (91.3%) | 127 | 5.15 | |
| Missing data | 3 (3.7%) | 0 (0%) | 79 (96.4%) | 82 | 6.99 | |
| Questioning frequency | Daily | NA | 0 (0%) | 55 (100%) | 55 | 4.68 |
| Weekly | NA | 9 (9.5%) | 86 (90.5%) | 95 | 4.49 | |
| Monthly | NA | 1 (1.3%) | 77 (98.8%) | 78 | 13.47 | |
| Annual+ | NA | 0 (0%) | 30 (100%) | 30 | 5.43 | |
| One off | NA | 3 (0.8%) | 385 (99.2%) | 388 | 6.76 | |
| Recall period | 1–3 days | NA | 1 (1.6%) | 60 (98.4%) | 61 | 25.88 |
| 4–14 days | NA | 11 (2.1%) | 520 (97.9%) | 531 | 5.22 | |
| 15–30 days | NA | 1 (2.6%) | 37 (97.4%) | 38 | 3.94 | |
| 31–90 days | NA | 0 (0%) | 13 (100%) | 13 | 1.00 | |
| 91+ days | NA | 0 (0%) | 3 (12.5%) | 3 | 1.83 |
FIGURE 1PRISMA diagram of the systematic review
A random effects model showing the association between study characteristics and estimated diarrhoea rates for all observations and only active surveillance observations
| Active vs. Passive | Within active | ||||
|---|---|---|---|---|---|
| IRR | 95% CI | IRR | 95% CI | ||
| Surveillance type |
Reference: Active surveillance Passive surveillance | Ref. | Ref. | Ref. | Ref. |
| 0.03 | (0.02, 0.06) | NA | NA | ||
| Region | Reference: Sub‐Saharan Africa | Ref. | Ref. | Ref. | Ref. |
| North Africa/Middle East | 1.31 | (0.44, 3.87) | 1.32 | (0.45, 3.86) | |
| Central and South Asia | 0.88 | (0.13, 6.14) | 0.87 | (0.13, 6) | |
| Eastern and South‐East Asia | 1.21 | (0.47, 3.07) | 1.2 | (0.47, 3.07) | |
| Oceania | 1.12 | (1.05, 1.19) | 1.11 | (1.05, 1.17) | |
| South America and Caribbean | 0.63 | (0.47, 0.84) | 0.67 | (0.51, 0.9) | |
| Year | Year | 0.97 | (0.96, 0.98) | 0.97 | (0.97, 0.98) |
| Region and year | Reference: Sub‐Saharan Africa | Ref. | Ref. | Ref. | Ref. |
| North Africa/Middle East | 0.99 | (0.95, 1.02) | 0.99 | (0.95, 1.02) | |
| Central and South Asia | 0.99 | (0.93, 1.06) | 0.99 | (0.93, 1.06) | |
| Eastern and South‐East Asia | 0.99 | (0.96, 1.02) | 0.99 | (0.96, 1.02) | |
| Oceania | 1.00 | (1.00, 1.00) | 1.00 | (1.00, 1.00) | |
| The Americas | 1.02 | (1.01, 1.03) | 1.02 | (1.01, 1.03) | |
| Study design | Reference: Observational primary | Ref. | Ref. | Ref. | Ref. |
| Observational secondary | 1.05 | (0.89, 1.22) | 1.04 | (0.89, 1.22) | |
| RCT (baseline or control) | 1.19 | (0.85, 1.67) | 1.5 | (1.12, 2.02) | |
| RCT (experimental post‐intervention) | 1.04 | (0.75, 1.43) | 1.33 | (0.98, 1.79) | |
| Log of measurement period | NA | NA | 0.52 | (0.46, 0.60) | |
| Questioning frequency | Reference: Daily | NA | NA | NA | NA |
| Weekly | NA | NA | 1.24 | (0.77, 1.99) | |
| Monthly | NA | NA | 2.57 | (1.36, 4.84) | |
| Annually or longer | NA | NA | 4.8 | (2.73, 8.45) | |
| One off | NA | NA | 4.22 | (2.73, 6.52) | |
| Method | Reference: Diary | NA | NA | Ref. | Ref. |
| Self‐report | NA | NA | 0.85 | (0.53, 1.38) | |
| Constant | 7.98 | (5.72, 11.14) | 13.86 | 7.3 | |
| Random effects parameters | Variance (constant) | 1.07 | (0.86, 1.33) | 0·67 | (0.47, 0.95) |
| Variance (residual) | 0.08 | (0.06, 0.11) | 0·08 | (0.05, 0.11) | |
FIGURE 2(a) Box plot of estimated diarrhoea rate against questioning frequency for active surveillance studies. (b) Scatter plot and trendline of estimated diarrhoea rates against recall period for active surveillance studies
| Number of observations per study | Number of studies (%) |
|---|---|
| 1 | 175 (60.14) |
| 2 | 62 (21.31) |
| 3 | 14 (4.81) |
| 4 | 19 (6.53) |
| 5 | 6 (2.06) |
| 6 | 3 (1.03) |
| 7 | 2 (0.69) |
| 8 | 1 (0.34) |
| 10 | 1 (0.34) |
| 12 | 1 (0.34) |
| 15 | 1 (0.34) |
| 16 | 2 (0.69) |
| 17 | 1 (0.34) |
| 21 | 1 (0.34) |
| 34 | 1 (0.34) |